{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:25:08Z","timestamp":1794435908463,"version":"4.9.1"},"reference-count":96,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1053\/j.semnuclmed.2026.07.013","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T21:07:04Z","timestamp":1786741624000},"page":"916-929","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["PET\/CT In paediatric lymphoma: Current role and advances"],"prefix":"10.1053","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6754-4553","authenticated-orcid":false,"given":"Akinwale","family":"Ayeni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tebatso","family":"Tebeila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mampoi","family":"Jonas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osayande","family":"Evbuomwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.semnuclmed.2026.07.013_bib0001","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-11278-2","article-title":"Clinical characteristics and short-term outcomes of pediatric lymphoma: a retrospective cohort study from a large tertiary hospital in a low- and middle-income country","volume":"15","author":"Abuhalima","year":"2025","journal-title":"Sci Rep"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.07.013_bib0002","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/j.semnuclmed.2022.10.001","article-title":"Overview and recent advances in 18F-FDG PET\/CT for evaluation of pediatric lymphoma","volume":"53","author":"Guja","year":"2023","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2026.07.013_bib0003","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.anndiagpath.2017.11.006","article-title":"A retrospective analysis of paediatric lymphomas at chris hani baragwanath academic hospital in Soweto, South Africa","volume":"33","author":"Padayachee","year":"2018","journal-title":"Ann Diagn Pathol"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.07.013_bib0004","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1007\/s00277-025-06445-4","article-title":"Epidemiologic trends for pediatric Hodgkin and non-hodgkin lymphomas: a U.S. population-based study","volume":"104","author":"Cheng","year":"2025","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.07.013_bib0005","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00259-009-1276-9","article-title":"Role of PET\/CT in malignant pediatric lymphoma","volume":"37","author":"Riad","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.07.013_bib0006","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00247-025-06476-z","article-title":"Advances in FDG PET imaging for staging and prognostic assessment in pediatric lymphoma: a systematic review","volume":"56","author":"Ghazi","year":"2026","journal-title":"Pediatr Radiol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.07.013_bib0007","doi-asserted-by":"crossref","DOI":"10.4084\/MJHID.2024.078","article-title":"Pediatric Hodgkin lymphoma in low- and middle-income countries (LMICs). A narrative review","volume":"16","author":"Moleti","year":"2024","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.07.013_bib0008","article-title":"Epidemiology and etiology of leukemia and lymphoma. cold spring harbor perspectives in","volume":"10","author":"Bispo","year":"2020","journal-title":"Medicine"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.07.013_bib0009","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/MPH.0b013e3182913e6a","article-title":"Children with cancer and HIV infection: what is different about them?","volume":"35","author":"Stefan","year":"2013","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.07.013_bib0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/MPH.0b013e31829cdd49","article-title":"Malignancies in South African children with HIV","volume":"36","author":"Davidson","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.07.013_bib0011","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00428-024-03980-9","article-title":"Pediatric lymphomas: overview and diagnostic challenges","volume":"486","author":"Choi","year":"2025","journal-title":"Virchows Arch"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.07.013_bib0012","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/bjh.15789","article-title":"Epidemiology, outcome, targeted agents and immunotherapy in adolescent and young adult non-hodgkin and Hodgkin lymphoma","volume":"185","author":"Metzger","year":"2019","journal-title":"Br J Haematol"},{"issue":"32","key":"10.1053\/j.semnuclmed.2026.07.013_bib0013","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1200\/JCO.2013.52.5410","article-title":"Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's oncology group study AHOD0031","volume":"32","author":"Friedman","year":"2014","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1053\/j.semnuclmed.2026.07.013_bib0014","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1200\/JCO.2009.26.9381","article-title":"Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study","volume":"28","author":"Mauz-K\u00f6rholz","year":"2010","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.07.013_bib0015","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1053\/j.semnuclmed.2017.01.001","article-title":"Current role of FDG-PET in pediatric Hodgkin's lymphoma","volume":"47","author":"Kluge","year":"2017","journal-title":"Semin Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.07.013_bib0016","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/bjh.16014","article-title":"Response-adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children's Oncology Group","volume":"187","author":"Kelly","year":"2019","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.07.013_bib0017","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s12288-024-01878-9","article-title":"Efficiency of PET-CT in reducing the usage of radiotherapy in childhood Hodgkin lymphoma: a single center experience","volume":"41","author":"Milosevic","year":"2025","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"27","key":"10.1053\/j.semnuclmed.2026.07.013_bib0018","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.07.013_bib0019","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.07.013_bib0020","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1200\/JCO.2006.08.2305","article-title":"Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging subcommittee of international harmonization project in lymphoma","volume":"25","author":"Juweid","year":"2007","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1053\/j.semnuclmed.2026.07.013_bib0021","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1200\/JCO.2005.01.904","article-title":"Role of positron emission tomography in lymphoma","volume":"23","author":"Juweid","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.07.013_bib0022","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000329","article-title":"Risk and response adapted treatment guidelines for managing first relapsed and refractory classical hodgkin lymphoma in children and young people. Recommendations from the EuroNet pediatric hodgkin lymphoma group","volume":"4","author":"Daw","year":"2020","journal-title":"Hemasphere"},{"issue":"18","key":"10.1053\/j.semnuclmed.2026.07.013_bib0023","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1200\/JCO.2014.59.7203","article-title":"Revised International pediatric Non-hodgkin lymphoma staging system","volume":"33","author":"Rosolen","year":"2015","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.07.013_bib0024","first-page":"461","article-title":"[Prognostic factors in Hodgkin and non-Hodgkin lymphomas]","volume":"96","author":"Cuenca","year":"2009","journal-title":"Bull Cancer"},{"key":"10.1053\/j.semnuclmed.2026.07.013_bib0025","series-title":"Cancer: Disease Control Priorities","article-title":"Treating childhood cancer in low- and middle-income countries","volume":"3","author":"Gupta","year":"2015"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.07.013_bib0026","doi-asserted-by":"crossref","DOI":"10.1200\/EDBK_432420","article-title":"Pediatric and adolescent Hodgkin Lymphoma: paving the way for standards of care and shared decision making","volume":"44","author":"Kahn","year":"2024","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.07.013_bib0027","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1080\/08880018.2022.2162651","article-title":"SACCSG HL-2018. Barriers and enablers of a harmonized treatment protocol for childhood and adolescent Hodgkin lymphoma in South Africa","volume":"40","author":"Geel","year":"2023","journal-title":"Pediat Hematol Oncol"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.07.013_bib0028","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S1470-2045(23)00019-0","article-title":"Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study","volume":"24","author":"Mauz-K\u00f6rholz","year":"2023","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.07.013_bib0029","first-page":"253","article-title":"State of the art in the management of pediatric lymphoma","volume":"69","author":"Flerlage","year":"2025","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"16","key":"10.1053\/j.semnuclmed.2026.07.013_bib0030","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1182\/bloodadvances.2020002178","article-title":"El-Mallawany NK. Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa","volume":"4","author":"Ozuah","year":"2020","journal-title":"Blood Adv"},{"issue":"7","key":"10.1053\/j.semnuclmed.2026.07.013_bib0031","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2006-07-036673","article-title":"Results of the randomized international FAB\/LMB96 trial for intermediate risk B-cell non-hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients","volume":"109","author":"Patte","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.semnuclmed.2026.07.013_bib0032","article-title":"Treatment outcomes and survival analysis of pediatric mature B-cell non-hodgkin lymphoma: a retrospective study comparing LMB96 and R-CHOP regimens","volume":"24","author":"Rjeib","year":"2025","journal-title":"Leuk Res Rep"},{"key":"10.1053\/j.semnuclmed.2026.07.013_bib0033","article-title":"Brentuximab vedotin use in pediatric anaplastic large cell lymphoma","volume":"14 - 2023","author":"Agrusa","year":"2023","journal-title":"Front Immunol"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.07.013_bib0034","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00259-008-0826-x","article-title":"Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology","volume":"35","author":"Stauss","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.07.013_bib0035","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00259-002-0861-y","article-title":"18)F]FDG in childhood lymphoma: clinical utility and impact on management","volume":"29","author":"Montravers","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.07.013_bib0036","first-page":"1","article-title":"Staging in childhood lymphoma: differences between FDG-PET and CT","volume":"44","author":"Hermann","year":"2005","journal-title":"Nuklearmedizin"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.07.013_bib0037","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00259-004-1604-z","article-title":"18F-FDG PET in children with lymphomas","volume":"32","author":"Depas","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.07.013_bib0038","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00247-006-0152-z","article-title":"F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas","volume":"36","author":"Hernandez-Pampaloni","year":"2006","journal-title":"Pediatr Radiol"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.07.013_bib0039","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/00004728-200607000-00022","article-title":"Role of 18F-FDG PET\/CT in staging and follow-up of lymphoma in pediatric and young adult patients","volume":"30","author":"Miller","year":"2006","journal-title":"J Comput Assist Tomogr"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.07.013_bib0040","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s00247-003-1114-3","article-title":"PET imaging in pediatric Hodgkin's lymphoma","volume":"34","author":"Hudson","year":"2004","journal-title":"Pediatr Radiol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.07.013_bib0041","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2967\/jnumed.120.254110","article-title":"SNMMI procedure Standard\/EANM practice guideline on pediatric (18)F-FDG PET\/CT for oncology 1.0","volume":"62","author":"Vali","year":"2021","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.07.013_bib0042","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3390\/diagnostics13020192","article-title":"The impact of PET\/CT on paediatric oncology","volume":"13","author":"Brink","year":"2023","journal-title":"Diagnostics"},{"key":"10.1053\/j.semnuclmed.2026.07.013_bib0043","article-title":"Normal variants and pitfalls of 18F-FDG PET\/CT imaging in pediatric oncology","volume":"2 - 2022","author":"Purbhoo","year":"2022","journal-title":"Front Nucl Med"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.07.013_bib0044","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00259-005-0019-9","article-title":"Comparison of 18F-FDG-PET and standard procedures for the pretreatment staging of children and adolescents with Hodgkin's disease","volume":"33","author":"Kabickova","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.07.013_bib0045","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s00247-012-2559-z","article-title":"FDG PET\/CT in children and adolescents with lymphoma","volume":"43","author":"Kluge","year":"2013","journal-title":"Pediatr Radiol"},{"issue":"supplement 1","key":"10.1053\/j.semnuclmed.2026.07.013_bib0046","first-page":"374","article-title":"Can F-18-FDG PET-CT avoid unyielding iliac crest biopsy in evaluation of marrow involvement by lymphoma at the time of initial staging?","volume":"52","author":"Kuruva","year":"2011","journal-title":"J Nucl Med"},{"issue":"26","key":"10.1053\/j.semnuclmed.2026.07.013_bib0047","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1200\/JCO.2010.32.4996","article-title":"18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma","volume":"29","author":"Purz","year":"2011","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1053\/j.semnuclmed.2026.07.013_bib0048","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1007\/s00330-018-5306-5","article-title":"PET\/CT predicts bone marrow involvement in paediatric non-Hodgkin lymphoma and may preclude the need for bone marrow biopsy in selected patients","volume":"28","author":"Chen","year":"2018","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.07.013_bib0049","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/1042819031000149430","article-title":"FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma: a blinded comparison","volume":"45","author":"Friedberg","year":"2004","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.07.013_bib0050","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1007\/s00330-020-07182-0","article-title":"Whole-body MRI versus an FDG-PET\/CT-based reference standard for staging of paediatric Hodgkin lymphoma: a prospective multicentre study","volume":"31","author":"Spijkers","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1053\/j.semnuclmed.2026.07.013_bib0051","article-title":"A meta-analysis on the diagnostic performance of whole-body MRI for the initial staging of Hodgkin lymphoma in children and adults using FDG-PET\/CT as a reference standard","volume":"1","author":"Spijkers","year":"2023","journal-title":"EJC Paediatr Oncol"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.07.013_bib0052","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1007\/s00247-020-04683-4","article-title":"Whole-body magnetic resonance imaging in pediatric oncology - recommendations by the oncology task force of the ESPR","volume":"50","author":"Sch\u00e4fer","year":"2020","journal-title":"Pediatr Radiol"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.07.013_bib0053","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00277-022-04789-9","article-title":"A comparison of FDG PET\/MR and PET\/CT for staging, response assessment, and prognostic imaging biomarkers in lymphoma","volume":"101","author":"Husby","year":"2022","journal-title":"Ann Hematol"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.07.013_bib0054","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/10428190903040048","article-title":"Report on the first international workshop on Interim-PET-scan in lymphoma","volume":"50","author":"Meignan","year":"2009","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.07.013_bib0055","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood-2005-06-2252","article-title":"FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma","volume":"107","author":"Hutchings","year":"2006","journal-title":"Blood"},{"issue":"24","key":"10.1053\/j.semnuclmed.2026.07.013_bib0056","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1200\/JCO.2007.11.6525","article-title":"Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study","volume":"25","author":"Gallamini","year":"2007","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.07.013_bib0057","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1102\/1470-7330.2012.9006","article-title":"FDG-PET\/CT based response-adapted treatment","volume":"12","author":"de Geus-Oei","year":"2012","journal-title":"Cancer Imaging"},{"issue":"25","key":"10.1053\/j.semnuclmed.2026.07.013_bib0058","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1510093","article-title":"Adapted treatment guided by interim PET-CT scan in advanced Hodgkin\u2019s lymphoma","volume":"374","author":"Johnson","year":"2016","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.07.013_bib0059","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005973","article-title":"Pediatric Hodgkin Lymphoma: predictive value of interim 18F-FDG PET\/CT in therapy response assessment","volume":"96","author":"Ferrari","year":"2017","journal-title":"Med (Baltim)"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.07.013_bib0060","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.semnuclmed.2022.09.001","article-title":"Modern PET-guided radiotherapy planning and treatment for malignant lymphoma","volume":"53","author":"Pepper","year":"2023","journal-title":"Semin Nucl Med"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.07.013_bib0061","doi-asserted-by":"crossref","first-page":"733","DOI":"10.6004\/jnccn.2021.0027","article-title":"Pediatric Hodgkin Lymphoma, Version 3.2021","volume":"19","author":"Flerlage","year":"2021","journal-title":"J Natl Compr Cancer Netw"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.07.013_bib0062","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 4","key":"10.1053\/j.semnuclmed.2026.07.013_bib0063","article-title":"Imaging recommendations in pediatric lymphoma: a COG diagnostic imaging committee\/SPR oncology committee white paper","volume":"70 Suppl 4","author":"Mhlanga","year":"2023","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.07.013_bib0064","article-title":"Recent breakthroughs in PET-CT multimodality imaging: innovations and clinical impact","volume":"11","author":"Hussain","year":"2024","journal-title":"Bioeng (Basel)"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.07.013_bib0065","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1053\/j.semnuclmed.2024.10.007","article-title":"Long axial field-of-view PET\/CT: new opportunities for pediatric imaging","volume":"55","author":"Dias","year":"2025","journal-title":"Semin Nucl Med"},{"issue":"1094","key":"10.1053\/j.semnuclmed.2026.07.013_bib0066","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20180584","article-title":"(18)F-FDG PET-CT in paediatric oncology: established and emerging applications","volume":"92","author":"Chambers","year":"2019","journal-title":"Br J Radiol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.07.013_bib0067","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2214\/AJR.10.4923","article-title":"A systematic review of the factors affecting accuracy of SUV measurements","volume":"195","author":"Adams","year":"2010","journal-title":"Am J Roentgenol"},{"issue":"1127","key":"10.1053\/j.semnuclmed.2026.07.013_bib0068","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20210448","article-title":"Total tumor burden in lymphoma - an evolving strong prognostic parameter","volume":"94","author":"Meignan","year":"2021","journal-title":"Br J Radiol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.07.013_bib0069","first-page":"83","article-title":"PET\/CT in pediatric oncology","volume":"10","author":"Masselli","year":"2020","journal-title":"Am J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.07.013_bib0070","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40644-025-00904-x","article-title":"\u0394SUVmax adds prognostic value to early response assessment during the first-line treatment of classical hodgkin lymphoma: a retrospective cohort study","volume":"25","author":"Pincz\u00e9s","year":"2025","journal-title":"Cancer Imaging"},{"issue":"7","key":"10.1053\/j.semnuclmed.2026.07.013_bib0071","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s00259-014-2715-9","article-title":"qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma","volume":"41","author":"Hasenclever","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"21","key":"10.1053\/j.semnuclmed.2026.07.013_bib0072","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2016-05-718528","article-title":"Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy","volume":"128","author":"Cheson","year":"2016","journal-title":"Blood"},{"issue":"19","key":"10.1053\/j.semnuclmed.2026.07.013_bib0073","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1200\/JCO.2016.72.1316","article-title":"Phase II study of the efficacy and safety of Pembrolizumab for relapsed\/refractory classic Hodgkin lymphoma","volume":"35","author":"Chen","year":"2017","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1053\/j.semnuclmed.2026.07.013_bib0074","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/bloodadvances.2020001900","article-title":"High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma","volume":"4","author":"Dean","year":"2020","journal-title":"Blood Adv"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.07.013_bib0075","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.6004\/jnccn.2020.7608","article-title":"Novel therapies potentially available for pediatric B-cell non-hodgkin lymphoma","volume":"18","author":"Harker-Murray","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"issue":"11","key":"10.1053\/j.semnuclmed.2026.07.013_bib0076","doi-asserted-by":"crossref","DOI":"10.3390\/jpm13111595","article-title":"CAR-T cell therapy in the treatment of pediatric non-hodgkin lymphoma","volume":"13","author":"Ostojska","year":"2023","journal-title":"J Pers Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.07.013_bib0077","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s00259-022-06001-6","article-title":"Joint EANM\/SNMMI guideline on radiomics in nuclear medicine: jointly supported by the EANM physics committee and the SNMMI physics, instrumentation and data sciences council","volume":"50","author":"Hatt","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.07.013_bib0078","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2967\/jnumed.118.222893","article-title":"Introduction to radiomics","volume":"61","author":"Mayerhoefer","year":"2020","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.07.013_bib0079","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/j.semnuclmed.2020.09.002","article-title":"Radiomics in PET\/CT: current status and future AI-based evolutions","volume":"51","author":"Hatt","year":"2021","journal-title":"Semin Nucl Med"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.07.013_bib0080","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1097\/MNM.0000000000002046","article-title":"Automatic Lugano staging for risk stratification in lymphoma: a multicenter PET radiomics and machine learning study with survival analysis","volume":"46","author":"Hasanabadi","year":"2025","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2026.07.013_bib0081","unstructured":"Pan, B., Zhang, Z., Meng, H., et al. AutoLugano: a deep learning framework for fully automated lymphoma segmentation and Lugano staging on FDG-PET\/CT. arXiv preprint arXiv:251207206. 2025."},{"key":"10.1053\/j.semnuclmed.2026.07.013_bib0082","doi-asserted-by":"crossref","DOI":"10.1007\/s00247-026-06606-1","article-title":"Application of artificial intelligence in paediatric oncology imaging","author":"De Donno","year":"2026","journal-title":"Pediatr Radiol"},{"issue":"7","key":"10.1053\/j.semnuclmed.2026.07.013_bib0083","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.2967\/jnumed.118.215418","article-title":"Performance characteristics of the Digital Biograph vision PET\/CT system","volume":"60","author":"van Sluis","year":"2019","journal-title":"J Nucl Med"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.07.013_bib0084","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3390\/diagnostics15091070","article-title":"Will PET\/MR imaging replace PET\/CT for pediatric applications?","volume":"15","author":"Masselli","year":"2025","journal-title":"Diagnostics"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.07.013_bib0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2967\/jnumed.116.184028","article-title":"Total-body PET: maximizing sensitivity to create new opportunities for clinical research and patient care","volume":"59","author":"Cherry","year":"2018","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.07.013_bib0086","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40658-020-00290-2","article-title":"State of the art in total body PET","volume":"7","author":"Vandenberghe","year":"2020","journal-title":"EJNMMI Phys"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.07.013_bib0087","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.cpet.2024.05.005","article-title":"Long-axial field-of-view PET imaging in patients with lymphoma: challenges and opportunities","volume":"19","author":"Mingels","year":"2024","journal-title":"PET Clin"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.07.013_bib0088","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2967\/jnumed.119.226498","article-title":"First Human imaging studies with the EXPLORER total-body PET scanner*","volume":"60","author":"Badawi","year":"2019","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.07.013_bib0089","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1053\/j.semnuclmed.2022.01.002","article-title":"Total-body PET\/CT - first clinical experiences and future perspectives","volume":"52","author":"Ng","year":"2022","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2026.07.013_bib0090","article-title":"QUALIPAED-A retrospective quality control study evaluating pediatric long axial field-of-view low-dose FDG-PET\/CT","volume":"4","author":"Honor\u00e9 d'Este","year":"2024","journal-title":"Front Nucl Med"},{"key":"10.1053\/j.semnuclmed.2026.07.013_bib0091","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6045894","article-title":"A pilot study of 18F-FLT PET\/CT in pediatric lymphoma","volume":"2016","author":"Costantini","year":"2016","journal-title":"Int J Mol Imaging"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.07.013_bib0092","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2967\/jnumed.123.265530","article-title":"Fibroblast activation protein and glycolysis in lymphoma diagnosis: comparison of 68Ga-FAPI PET\/CT and 18F-FDG PET\/CT","volume":"64","author":"Chen","year":"2023","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2026.07.013_bib0093","article-title":"The role of FAPI PET\/CT in patients with lymphoma: a systematic review","volume":"5 - 2025","author":"Quartuccio","year":"2025","journal-title":"Front Nucl Med"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.07.013_bib0094","doi-asserted-by":"crossref","DOI":"10.5306\/wjco.v16.i9.108585","article-title":"Immuno-positron emission tomography as a new frontier in imaging hematologic malignancies","volume":"16","author":"Goto","year":"2025","journal-title":"World J Clin Oncol"},{"issue":"11","key":"10.1053\/j.semnuclmed.2026.07.013_bib0095","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12112485","article-title":"Recent updates of PET in lymphoma: FDG and beyond","volume":"12","author":"Kim","year":"2024","journal-title":"Biomedicines"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.07.013_bib0096","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1158\/0008-5472.CAN-16-3346","article-title":"Granzyme B PET imaging as a predictive biomarker of immunotherapy response","volume":"77","author":"Larimer","year":"2017","journal-title":"Cancer Res"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299826001510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299826001510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:27:55Z","timestamp":1794432475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299826001510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":96,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0001299826001510"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2026.07.013","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PET\/CT In paediatric lymphoma: Current role and advances","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2026.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}